MDCT EVALUATION OF COLORECTAL LESIONS
Journal Title: International Journal of Recent Scientific Research - Year 2017, Vol 8, Issue 2
Abstract
Colorectal lesions always been challenging as well as intriguing in their anatomical,surgical and post-surgical management related issues.they are heterogenous set of pathologies involving different age groups.our objective is to characterise colorectal lesions by mdct and differentiating benign and malignant colorectal lesions by histopathological comparison
Authors and Affiliations
Bodapati N V V D Prasad, Siddesh M B, Jeevika M U, K N Shivamurthy
Personality and perceived stress among medical college students
Objectives: The present research was framed to investigate the relationship between personality traits (Neuroticism and Psychoticism tendencies) and perceived stress among medical college students. Methods: The sample in...
Maxillofacial trauma and post traumatic stress disorder
Injuries to the maxillofacial skeleton have become very common in the present scenario. It may vary from simple lacerated wounds to fractures of the bones constituting the facial skeleton. Since the society as become mor...
Knowledge, attitude and awareness about general anaesthesia among dental students
Background: General anaesthesia is the state produced when a patient receives medications for amnesia, analgesia, muscle paralysis, and sedation. An anaesthetised patient can be thought of as being in a controlled, rever...
Effect of tanzberger exercise versus kegel exercise on pelvic floor muscle strength in postmenopausal women with stress incontinence- an experimental study
Background: Stress urinary incontinence, the complaint of involuntary leakage during effort or exertion, occurs at least weekly in one third of adult women. It affects not only the patient, but also her family and societ...
Anti-diabetic potential of herbal medicinal plants
Diabetes mellitus is probably the common metabolic disorders and a couple of. 8% with the population is suffering from this disease across the world which may well cross 5. 4% from the year 2025. Oral anti-hyperglycemic...